Mesoblast
Founded
2004
2004
Patents
54
54
Clinical Trials
32
32
Publications
43
43
Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC)
technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney
disease, orthopedic spine conditions, and cardiovascular disorders.
Get access to BPT Crunch to view additional information about this company